Introduction
Materials and methods
Study design
Treatment
Subjects for analysis
Variables
Statistics
Results
Patient characteristics
With subsequent chemotherapy n = 17 | ||
---|---|---|
Age (year-old)
|
71 (45–76)
| |
Sex (male: female)
|
13:4
| |
Tumor stage IV, n (%)
|
11 (64.7)
| |
ECOG PS (0:1)
|
17:0
| |
Smoking history, n (%)
|
9 (52.9)
| |
Brinkman index
|
500.0 (0-1530)
| |
History of lung disease, n (%)
|
0 (0)
| |
Emphysema on CT scan, n (%)
|
4 (23.5)
| |
Treatment, 1st line vs. later
|
15 (88.2)
| |
CEA (ng/mL)
|
5.9 (1.3-109.1)
| |
CA19-9 (U/mL)
|
200.4 (2.1–8543.0)
| |
KL-6 (U/mL)
|
356.0 (187.0-1784.0)
| |
SP-D (ng/mL)
|
198.6 (50.2-530.2)
| |
ILD grade 1/2/3/4, n (%)
|
7 (41.1)/6 (35.3)/4 (23.5)/0 (0)
|
Selection and toxicity of subsequent chemotherapy after ILD
S-1 n = 13 | FOLFOX n = 4 | p-value | ||
---|---|---|---|---|
Age (year-old)
|
70.5 (45–76)
|
67 (57–74)
|
0.61
| |
Sex (male:female)
|
11:2
|
2:2
|
0.21
| |
Tumor stage (cStage III: IV)
|
5:8
|
1:3
|
1.00
| |
ECOG PS (0:1)
|
13:0
|
4:0
|
1.00
| |
Smoking history, n (%)
|
7 (54.0)
|
2 (50.0)
|
1.00
| |
Brinkman index
|
960 (500–1530)
|
470 (200–740)
|
0.50
| |
History of lung disease, n (%)
|
0 (0)
|
0 (0)
|
1.00
| |
Presence of emphysema on CT scan, n (%)
|
3 (23.0)
|
1 (25.0)
|
1.00
| |
Treatment, 1st line, n (%)
|
11 (84.6)
|
4 (100.0)
|
1.00
| |
CEA (ng/mL)
|
6.6 (2.8–48.5)
|
2.6 (1.3–6.3)
|
0.06
| |
CA19-9 (U/mL)
|
73.9 (2.1–1990.0)
|
352.7 (130.4–4819)
|
0.11
| |
KL-6 (U/mL)
|
393.0 (187.0-1597.0)
|
271.5 (249.0-355.0)
|
0.13
| |
SP-D (ng/mL)
|
183.9 (88.0-442.4)
|
322.0 (145.7-530.2)
|
0.34
| |
ILD grade 1/2/3/4, n (%)
|
6 (46.2)/4 (30.8)/3 (23.1)/0
|
1 (25.0)/2 (50.0)/1 (25.0)/0
|
0.71
| |
Steroid therapy, n (%)
|
3 (23.0)
|
2 (50.0)
|
0.53
|
All cases n, (%) | S-1 n = 13 | FOLFOX n = 4 | p-value | ||
---|---|---|---|---|---|
Any grade ≥ 3 toxicity
|
4 (23.5)
4
|
3 (23.1)
|
1 (25.0)
|
0.93
| |
Hematological toxicity grade ≥ 3
| |||||
Neutropenia
|
2 (28.5)
|
1 (7.6)
|
1 (25.0)
|
0.34
| |
Febrile neutropenia
|
0
|
0
|
0
| ||
Thrombopenia/anemia
|
0
|
0
|
0
| ||
Non-hematological toxicity grade ≥ 3
|
2 (28.5)
|
2 (15.3)
|
0 (0)
|
0.40
| |
Anorexia
|
1 (5.9)
|
1 (7.6)
|
0
|
0.56
| |
Neuropathy
|
1 (5.9)
|
1 (7.6)
|
0
|
0.56
| |
Nausea/Vomiting
|
0
|
0
|
0
| ||
Diarrhea
|
0
|
0
|
0
|